Chemoinformaics analysis of Propyl isobutyrate
| Molecular Weight | 130.187 | nRot | 3 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 1 |
| Exact Molecular Weight | 130.099 | nRing | 0 |
| Solubility: LogS | -6.068 | nHRing | 0 |
| Solubility: LogP | 6.448 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.6291 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.345 |
| Synth | 2.085 |
| Natural Product Likeliness | 1.14 |
| NR-PPAR-gamma | 0.376 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.046 |
| HIA | 0.005 |
| CACO-2 | -4.551 |
| MDCK | 0.000017 |
| BBB | 0.195 |
| PPB | 0.971642 |
| VDSS | 3.107 |
| FU | 0.0209044 |
| CYP1A2-inh | 0.77 |
| CYP1A2-sub | 0.195 |
| CYP2c19-inh | 0.404 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.281 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.262 |
| CYP3a4-sub | 0.045 |
| CL | 7.012 |
| T12 | 0.243 |
| hERG | 0.127 |
| Ames | 0.005 |
| ROA | 0.013 |
| SkinSen | 0.961 |
| Carcinogencity | 0.062 |
| EI | 0.944 |
| Respiratory | 0.076 |
| NR-Aromatase | 0.349 |
| Antiviral | No |
| Prediction | 0.951564 |